Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Much Will The Fast Melt Tablets Market Be Worth By 2029?

In recent times, there has been a significant surge in the market size of fast melt tablets. It is projected to increase from $4.96 billion in 2024 to about $5.33 billion in 2025, following a Compound Annual Growth Rate (CAGR) of 7.5%. Factors contributing to the notable growth over the historic period include an aging population, a surge in chronic illnesses, an uptick in the self-medication trend, the expansion of the pharmaceutical sector, and rising disposable incomes.

The market for quick dissolve tablets is projected to experience robust growth in the forthcoming years. The market size is poised to reach “$7.18 billion by 2029” with a compound annual growth rate (CAGR) of 7.7%. The surge during the anticipated period is attributed to factors like the increasing occurrence of dysphagia, heightened preference for over-the-counter medication, growth of e-commerce, heightened demand for orally dissolvable drugs, and improving healthcare facilities. Significant trends predicted in the future include advancements in technology, novel formulation methods, use of nanotechnology, a move towards plant-derived excipients, and intelligent drug delivery systems.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23398&type=smp

Which Key Factors Are Fueling Growth In The Fast Melt Tablets Market?

The fast melt tablets market is projected to expand due to the escalating cases of heart attacks. A heart attack is a medical crisis resulting from an obstruction of the blood supply to the cardiac muscle, typically due to a blood clot or the accumulation of plaque in the coronary arteries. Factors such as increased consumption of processed foods leading to elevated cholesterol levels and heightened arterial plaque accumulation are contributing to the growing prevalence of heart attacks. Fast melt tablets allow for swift drug absorption supporting faster distribution of vital medications such as aspirin or nitroglycerin, which helps to prevent additional harm during a heart attack. They enhance patient outcomes by reestablishing blood supply and lessening the probability of severe complications. According to the British Heart Foundation’s report in January 2024, a UK-based cardiovascular research charity, over 39,000 premature deaths in England were due to cardiovascular conditions such as heart attacks, coronary heart disease, and stroke in 2022, translating to an average of 750 deaths weekly, the highest figure ever recorded. Consequently, the escalating occurrence of heart attacks is fuelling the fast melt tablets market’s expansion.

How Is The Fast Melt Tablets Market Segmented Across Key Categories?

The fast melt tablets market covered in this report is segmented –

1) By Type: Anti Psychotics, Anti Epileptics, Central Nervous System (CNS) Stimulants, Anxiolytics, Anti Parkinsonian Drugs, Anti Hypertensive, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Anti Allergy Drugs, Proton Pump Inhibitors, Other Types

2) By Indication: Pain Management, Allergy And Respiratory Disorders, Neurological Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Other Indications

3) By Dosage Form: Oral, Sublingual, Buccal, Chewable

4) By Age Group: Adult, Pediatrics, Geriatrics

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By Anti Psychotics: Atypical Antipsychotics, Typical Antipsychotics

2) By Anti Epileptics: Sodium Channel Blockers, Gamma-Aminobutyric Acid (GABA) Analogs, Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (AMPA) Receptor Antagonists, Carbonic Anhydrase Inhibitors

3) By Central Nervous System (CNS) Stimulants: Amphetamines, Methylphenidate, Modafinil, Xanthine Derivatives

4) By Anxiolytics: Benzodiazepines, Azapirones, Barbiturates, Antihistamines

5) By Anti Parkinsonian Drugs: Dopamine Agonists, Monoamine Oxidase-B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT) Inhibitors, Anticholinergics

6) By Anti Hypertensive: Beta Blockers, Calcium Channel Blockers, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics

7) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDS): Cyclooxygenase-1 (COX-1) Inhibitors, Cyclooxygenase-2 (COX-2) Inhibitors

8) By Anti Allergy Drugs: Antihistamines, Leukotriene Receptor Antagonists, Mast Cell Stabilizers, Corticosteroids

9) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole

10) By Other Types: Antiemetics, Antidepressants, Muscle Relaxants, Analgesics

What Key Trends Are Driving Growth In The Fast Melt Tablets Market?

Major firms in the quick dissolve tablet industry are prioritizing the creation of novel products such as quick dissolve tablets for greater patient comfort and quicker medication absorption. These Rapid Dissolving Tablets (RDTs) are solid medicine forms that are designed to swiftly dissolve in the mouth, eliminating the necessity for water. For example, Melt Pharmaceuticals, a US-based clinical-stage pharmaceutical firm, rolled out Melt 300 in December 2022. This advanced quick-dissolving tablet formulation was designed specifically for effective sedation. Comprised of midazolam (3 mg) and ketamine (50 mg), this inventive under-the-tongue quick-dissolving tablet ensures immediate effect and efficient sedation without the requirement for intravenous application. Melt 300 caters to the increasing demand for non-invasive, patient-friendly sedation options, improving procedural convenience while optimizing clinical workflows.

Which Firms Are Driving Innovation Within The Fast Melt Tablets Market?

Major companies operating in the fast melt tablets market are Pfizer Inc., Johnson & Johnson, Fuji Chemical Industries Co. Ltd., Teva Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Sun Pharmaceutical Industries Ltd, Catalent Inc., Aurobindo Pharma Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Centrient Pharmaceuticals B.V., Lannett Company Inc., Unichem Laboratories Ltd., SPI Pharma Inc., Windmill Health Products LLC, The Procter & Gamble Company, Perrigo Company plc, Melt Pharmaceuticals Inc., Imodium, Calpol, Akina Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/fast-melt-tablets-global-market-report

How Do Regional Dynamics Influence The Fast Melt Tablets Market Performance?

North America was the largest region in the fast melt tablets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fast melt tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=23398&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model